Olympic Ophthalmics

Executive Summary

Olympic Ophthalmics is a US-based medical device company founded in 2017 and headquartered in Las Vegas. Its core product, the iTEAR®100, is an FDA-cleared neurostimulation device that enables dry eye disease patients to produce natural tears without drugs or eye drops. The company operates a direct-to-consumer model requiring a prescription, facilitated through telehealth and physician partnerships. Dry eye disease affects millions, and the iTEAR100 offers a novel, drug-free alternative, positioning the company in a growing market with significant unmet need.

Upcoming Catalysts (preview)

• Q4 2026FDA clearance for over-the-counter use of iTEAR10030% success
• Q2 2027Major insurance coverage or CMS reimbursement decision40% success
• Q1 2027Publication of pivotal clinical study expanding indications50% success